Cognizant And Medidata Expand AI-Powered Clinical Trial Support
Cognizant and Medidata strengthen their partnership to advance AI-driven clinical trials, improving efficiency and patient outcomes.
Breaking News
Jan 31, 2025
Simantini Singh Deo
(1).png)
Cognizant expanded its agreement with Medidata, which is part of the Dassault Systèmes brand, to assist Medidata life sciences. The companies have collaborated for several years to create a complete support system for life sciences clients through services including implementation and engineering along with platform support from Medidata clinical platform and solutions. Through this renewed partnership, Medidata focuses on increasing its responsiveness and enhancing user satisfaction among organizations that depend on Medidata technology services for their clinical trial development needs.
"Our partnership with Cognizant represents a shared commitment to transforming clinical research through innovation and expertise. By combining Medidata's advanced AI-driven technologies with Cognizant's deep industry knowledge and operational excellence, we support life sciences organizations to streamline their R&D efforts, derive actionable insights from complex data, and ultimately bring life-changing therapies to patients more efficiently," said Janet Butler, EVP, Head of Global Sales, of Medidata. "
Under the terms of an extended partnership, Cognizant will assign Medidata Platform specialists to support all clients, including pharmaceutical, biotech, medical device, contract research organizations and patients using Medidata services. Medidata seeks to provide maximum value to customers working in the life sciences sector. Through this partnership, Medidata seeks to enhance the end-user experience so its business clients can devote their time to clinical trial development while improving patient healthcare results.
Mohammad Haque, SVP, Global Large Deals Lead and Business Unit Head, Life Sciences, of Cognizant, commented, "We are thrilled to accelerate our work with Medidata to help mutual clients leverage next-generation AI-enabled clinical capabilities on the unified Medidata Platform. Our collaboration aims to unlock the full potential of clients' clinical data and processes, improving user satisfaction and empowering them to make better-informed decisions faster for improved patient outcomes."
The extended multi-year partnership between Cognizant and Medidata focuses on enabling faster clinical trials through Medidata's AI-based technology programs. The integration of Medidata Clinical Data Studio, Medidata Health Record Connect, and the myMedidata patient portal together enable specific data experiences that help restructure R&D operations. The top partnership position as Global Medidata Strategic Alliance Partner enables Cognizant to utilize its broad network of Medidata Certified Services Professionals for modernizing life sciences organizations' clinical operations and data management.